ReviewClinical and translational science2025

Navigating Recent Changes in Dosing Information: Dynamics of FDA-Approved Monoclonal Antibodies in Post-Marketing Realities.

Nai Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.